Comparative efficacy and safety of gemtuzumab ozogamicin monotherapy and high-dose cytarabine combination therapy in patients with acute myeloid leukemia in first relapse.
Lance H. Leopold*, Mark S. Berger, Su Chun Cheng, Jorge E. Cortes-Franco, Francis J. Giles, Elihu H. Estey
Dive into the research topics of 'Comparative efficacy and safety of gemtuzumab ozogamicin monotherapy and high-dose cytarabine combination therapy in patients with acute myeloid leukemia in first relapse.'. Together they form a unique fingerprint.